Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 1
  • 5
  • 10
  • 3
  • 10

Found 10 Opioid Use Disorder trials

A listing of Opioid Use Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 General Screening Protocol for Affected and Unaffected Participants in Studies of Substance Use Disorders
18 years - 64 years
All genders
The goal of this study is to evaluate individuals with and without substance use disorder (SUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, or other research protocol that matches the participants’ interests and eligibility. Our goal is to enroll …
 Effects of opioid use disorder and non-fatal overdose on tau pathology; a [18F]PI-2620 PET/CT study
18 years - 60 years
All genders
Phase 2
This study is being conducted to learn more about how opioid use and opioid overdose affects tau levels in the brain. Tau is a protein in the brain that helps stabilize nerve cells structure. We will study tau levels in the brain using a type of Positron Emission Tomography (PET/CT) …
 Pilot Study of a Multi-System Analysis of Opioid Receptor Binding
18 years - 50 years
All genders
This study investigates opioid receptor binding in the brain and body. It aims to understand how these receptors, which are involved in pain reduction and reward experiences, function in different individuals.The study focuses on measuring the binding of a specific type of opioid receptor using a PET/CT scan. This involves …
99 years or below
All genders
Phase 2
Compare brain fMRI response to injectable extended-release buprenorphine (Brixadi, XR-BUP) and naltrexone (XR-NTX, Vivitrol) Our primary outcome combines adherence to treatment and the frequency of illicit opioid use during treatment. The primary outcome is a binary indicator of treatment success: Participants who provide 2 weekly UDS positive for opioids or …
99 years or below
All genders
Both HIV infection and exposure to opioids, including intravenous heroin in people who inject drugs (PWIDs), are associated with systemic immune activation due to, at least partially, dysbiosis and increased microbial translocation from the gut. Medication-assisted treatment (MAT) approaches based on the administration of Opioid Receptor (MOR) agonists (e.g. methadone) …
 RIDE+
18 years - 60 years
All genders
This research study will help us see whether providing medical services in a mobile unit will help persons who inject drugs (PWID) start and stay on anti-HIV medicines and medicines for opioid use disorder better.
 Emergency Department-Initiated Buprenorphine Validation Network Trial
18 years - 99 years
All genders
Interventional
The purpose of this research study is to compare two versions of the same medication buprenorphine, (commonly known as Suboxone) used to treat opioid use disorder, in patients in the Emergency Department (ED). One form of the medication is a slow-release form of buprenorphine (CAM2038) that lasts for about 7 …
 The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions: Randomized Trial
18 years - 99 years
All genders
We are interested in comparing 3 care conditions to determine which condition is best to help people with opioid use disorder (OUD) and mental illness reduce their drug use and improve their psychiatric symptoms. The model we are testing is called collaborative care. This model uses a team-based approach in …
 Evaluation of in vivo Neuroinflammation Using 18F-NOS (PET/CT) in HIV Positive and Negative Subjects with Opioid Use Disorder and Healthy Controls
18 years - 60 years
All genders
Phase 1
Study Purpose: The goal of this study is to learn more about how opiate use and HIV affects inflammation in the brain. We will study this using a type of Positron Emission Tomography (PET/CT) scan using a radioactive imaging drug called 18F-NOS that can be used to measure inflammation in …
99 years or below
All genders
Phase 4
The study participants will be in the study for approximately 2 months including the screening, intervention phase and the 6 weeks of follow-up time